NCT04499326 Improving Patient Reported Outcome Measures in Catheter Ablation
| NCT ID | NCT04499326 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barts & The London NHS Trust |
| Condition | Ventricular Tachycardia |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-06-13 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-06-13 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD). It is designed to have feasibility outcomes which contribute to answering the above.
Eligibility Criteria
Inclusion Criteria: Adults (\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD. And impaired LV/RV function Willing and able to give written informed consent Exclusion Criteria: Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent
Contact & Investigator
Pier Lambiase, PhD
STUDY CHAIR
UCL
Frequently Asked Questions
Who can join the NCT04499326 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ventricular Tachycardia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04499326 currently recruiting?
Yes, NCT04499326 is actively recruiting participants. Contact the research team at yang.chen@nhs.net for enrollment information.
Where is the NCT04499326 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT04499326 clinical trial?
NCT04499326 is sponsored by Barts & The London NHS Trust. The principal investigator is Pier Lambiase, PhD at UCL. The trial plans to enroll 70 participants.